Cary Street Partners’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.57M Sell
17,171
-31
-0.2% -$2.71K 0.03% 408
2026
Q1
$1.47M Sell
17,202
-341
-2% -$30.4K 0.04% 372
2025
Q4
$1.39M Sell
17,543
-61
-0.3% -$4.78K 0.03% 384
2025
Q3
$1.41M Sell
17,604
-518
-3% -$44.2K 0.04% 367
2025
Q2
$1.65M Buy
18,122
+69
+0.4% +$6.3K 0.05% 337
2025
Q1
$1.69M Sell
18,053
-239
-1% -$21.4K 0.05% 309
2024
Q4
$1.66M Buy
+18,292
New +$1.75M 0.05% 300

Other funds holding CL

Cary Street Partners's CL Position: Q2 2026 in Review

Cary Street Partners reduced its Colgate-Palmolive (CL) stake by 0.18% in Q2 2026, selling an estimated $2.71K and leaving 17,171 shares worth $1.57M. The position accounts for 0.03% of the portfolio, ranked #408.

Cary Street Partners first reported a position in CL in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.69M in Q1 2025. 597 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Cary Street Partners held 17,171 shares of Colgate-Palmolive worth $1.57M as of Q2 2026.
  • Cary Street Partners sold 31 Colgate-Palmolive shares in Q2 2026, an estimated $2.71K.
  • Colgate-Palmolive made up 0.03% of Cary Street Partners's portfolio in Q2 2026, its #408 holding.
  • Cary Street Partners first reported a position in Colgate-Palmolive in Q4 2024 and has held it in 7 quarters since.
  • Cary Street Partners's Colgate-Palmolive position peaked at $1.69M in Q1 2025.
  • 597 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Cary Street Partners's 13F filing for Q2 2026, filed 17 Jul 2026.